DVT: what to know about the blood clot plaguing NBA players
Multiple players have been diagnosed with deep vein thrombosis over the past few months


Over the last year or so, three high-profile NBA superstars have received blood clot disorder diagnoses. In just the last two months, both Damian Lillard of the Milwaukee Bucks and the San Antonio Spurs' Victor Wembanyama were diagnosed with deep vein thrombosis. Wembanyama's clot was discovered in his right shoulder, while Lillard's was found in his calf. While Lillard hopes to be back on the court in time for the playoffs, Ausar Thompson of the Detroit Pistons, who was diagnosed with a clot in March 2024, did not return to the game until November. Are these diagnoses suggestive of a larger problem for NBA players?
What is deep vein thrombosis?
DVT occurs when a "blood clot develops in a deep vein," most commonly in the lower leg, thigh or pelvis, though it can also occur in the arm, said the Centers for Disease Control and Prevention. When a part of the blood clot gets dislodged and travels to the lungs, the DVT can develop into a pulmonary embolism, which can be life-threatening. DVT and PE are "often underdiagnosed" and are both "serious, but often preventable medical conditions." Many people with DVT have no symptoms, but common signs to look for in the affected leg or arm include swelling, pain or tenderness, warmth, and redness or discoloration.
These blood clots can occur in people of any age but typically affect those older than 60. Other risk factors include a family history of clots, having given birth within the last 6 months, obesity and sitting in one position for too long, such as during bed rest or plane and car travel, said Mount Sinai. Certain behaviors or disorders can also put you at increased risk, including tobacco smoking, cancer, lupus and taking estrogen or birth control pills.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Some people with DVT may need to be treated in the hospital, and in rare cases, surgical intervention could be required. However, for many people, medications such as anticoagulants (blood thinners), compression socks and elevating the affected area are sufficient treatment, said the Mayo Clinic.
Is DVT more prominent among basketball players?
There may have been three recent cases in the NBA, but that does not necessarily mean there is an uptick among players. Professional athletes could be exposed to heightened risk factors for DVT, such as frequent plane travel, but "players are not flying drastically more of late than in the recent past," said The Athletic. Studies have suggested that taller people may be at greater risk, but player heights have not changed significantly either, cardiologist Cheng-Han Chen said to the outlet.
When it comes to developing DVT, it is not "genetics or familial," vascular surgeon Christopher Yi said to The Athletic. The condition "just randomly happens in certain people," but may be more common in people with "repetitive arm movements," like in the case of Wembanyama. And while there have been some changes to modern gameplay, such as basketball players taking more jump shots, experts do not think playstyle changes can be linked to increased DVT diagnoses.
Despite the recent trend in high-profile players, experts "wouldn't necessarily say there's a new epidemic of DVT," Chen said. There might be more talk about the condition because athletes and teams are "much more attuned to the possible diagnosis." The silver lining for those who have dealt with DVT recently is that their cases will help more athletes catch potential blood clots before they become serious. Chris Bosh was the "first big one that we all noticed once he got it" back in 2015, Chen said. Now, when athletes exhibit symptoms like pain or swelling, they alert their trainer faster and trainers are "more cognizant of it and more likely to do the testing for it."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
Music reviews: Bon Iver, Valerie June, and The Waterboys
Feature "Sable, Fable," "Owls, Omens, and Oracles," "Life, Death, and Dennis Hopper"
By The Week US
-
Are bonds worth investing in?
the explainer They can diversify your portfolio and tend to be a safer investment than stocks
By Becca Stanek, The Week US
-
Elon has his 'Legion.' How will Republicans encourage other Americans to have babies?
Today's Big Question The pronatalist movement finds itself in power
By Joel Mathis, The Week US
-
Protein obsession is oversaturating the health food space
Under the Radar Some experts say that fiber is now the most important macro to focus on
By Justin Klawans, The Week US
-
Strep infections are rising in the US
Under the radar The cases have more than doubled in 10 years
By Devika Rao, The Week US
-
Hantavirus: the rare pathogen linked to rodents that attacks the lungs
The Explainer Despite the low risk of contracting it, the virus could be potentially deadly
By Theara Coleman, The Week US
-
The sneaking rise of whooping cough
Under the Radar The measles outbreak isn't the only one to worry about
By Theara Coleman, The Week US
-
The tobacco industry could be the beneficiary of health agency cuts
The explainer Anti-tobacco initiatives may go up in smoke
By Devika Rao, The Week US
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
By Peter Weber, The Week US
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
By Peter Weber, The Week US
-
Tuberculosis sees a resurgence and is only going to get worse
Under the radar The spread of the deadly infection is buoyed by global unrest
By Devika Rao, The Week US